NEWS

News Articles

Four Emory professors named to American Academy of Arts and Sciences

May 5, 2022

Four Emory University faculty members have been elected to the American Academy of Arts and Sciences, one of the nation’s oldest and most prestigious honorary societies and a leading center for independent policy research. Elected this year are: Carlos del Rio, MD, executive associate dean, Emory School of Medicine & Grady Health System; Leon L.…

Read More

Georgia Tech’s Paul Joseph Awarded Fulbright Specialist Grant to India

May 4, 2022

Paul Joseph, a principal research scientist in the Institute for Electronics and Nanotechnology (IEN) at Georgia Tech, has received a Fulbright Specialist Award to India from the Fulbright Foreign Scholarship Board. Joseph will spend two weeks at the Indian Institute of Information technology (IIIT) this summer helping to expand the nanotechnology curriculum and assisting with…

Read More

Saol Therapeutics Announces First Patient Dosed in Phase 2 RAISE Spasticity Trial Evaluating the Safety Profile of SL-1002 for Limb Spasticity

May 4, 2022

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the first patient has been enrolled in the company’s Phase 2 RAISE Spasticity Trial.  SL-1002 is a novel, proprietary, nerve-blocking agent currently under development at Saol Therapeutics and is being evaluated in the RAISE Spasticity Trial.  The trial is a double-blind, placebo-controlled, single ascending-dose…

Read More

Missing our great physicist Sérgio Mascarenhas, defender of science

April 29, 2022

The passing of the scientist, physicist and chemist was mourned by all those who believe in scientific development, democratization of education and science as a way to build a fairer society in Brazil, with more health and access to all. Professor at the Institute of Physics of São Carlos, University of São Paulo, and honorary…

Read More

BioMarin Pharmaceutical commemorates 5 years of helping children with fatal rare disease

April 29, 2022

CLN2 Batten disease is a rare, inherited, fatal disorder that primarily affects the nervous system as a result of a failure to produce enough of the enzyme TPP1. The signs and symptoms of this condition typically start between the ages of 2 and 4, featuring recurrent seizures and coordination difficulty. BioMarin Pharmaceutical in San Rafael…

Read More

Saol Therapeutics and InformedDNA Partner to Offer Genetic Counseling to Patients with Rare Mitochondrial Disease

April 28, 2022

Program Discusses Access to a Pivotal Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency (DCA/PDCD trial; NCT02616484) Saol Therapeutics, a company researching new treatments for rare diseases, is pleased to announce a partnership with InformedDNA®, the nation’s leading applied genomics solutions company, to offer genetic counseling for the families of individuals with a…

Read More